Back to search

University of Thessaly (UTH)

Η μελέτη της φυσικής ιστορίας της πρωτοπαθούς χολικής κίρρωσης

Abstract

dc:description

Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease which can lead to end-stage liver disease if left untreated. Over recent decades, the epidemiology and natural history of the disease have evolved, with patients being diagnosed at an older age and at earlier stages of the disease, alongside the emergence of new therapeutic options. The aim of the present study was to analyze patients’ and disease’s characteristics in a large cohort of PBC patients from Greece and to investigate factors associated with disease progression and adverse outcomes. This retrospective analysis utilized prospectively collected data from 860 well-characterized PBC patients at our center. Females constituted 85.2% of the cohort, with a mean age at diagnosis of 56±14 years and a median follow-up duration of 5 (0.5-22) years. At diagnosis, 52% of the patients were symptomatic, while 15.6% had established cirrhosis, nearly half of whom experienced decompensation. Anti- mitochondrial antibodies (AMA) were detected in 97.6% (839/860) of patients, whereas antinuclear (ANA) – PBC specific autoantibodies (anti-gp210 and/or anti-sp100), were present in 16.3% (140/860). Patients positive for ANA were older and exhibited a more active disease, including elevated AST, ALT, γGT, IgM levels, and lower albumin. Urso-deoxycholic acid (UDCA) was administered to 89.4% (769/860) of patients. Treatment response was assessed using the Paris II criteria and the GLOBE score, with complete response rates of 75.9% and 68.9%, respectively. Patients positive for anti-sp100 demonstrated reduced response to UDCA therapy based on the GLOBE score (p=0.05). Second-line therapies were applied in 7% of cases.At the final evaluation, 7.1% (61/860) of patients had either died from liver-related causes or undergone liver transplantation. Multivariate analysis identified older age, presence of cirrhosis at diagnosis, coexistence of other liver diseases, and non-response to therapy as factors associated with worse outcome (p<0.05). During follow-up 5.1% (44/860) of patients experienced disease progression (including cirrhosis development, decompensation of cirrhosis, or hepatocellular carcinoma occurrence). Factors associated with disease progression included older age, non-response to therapy and cirrhosis at diagnosis (p<0.05). This study of the natural history of PBC in a large Greek cohort with long-term follow-up confirms that older age at diagnosis and lack of response to treatment are significant predictors of poor prognosis. Early identification of these patients is crucial to ensure close monitoring and timely initiation of second-line therapies to prevent disease progression.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Lygoura, Vasiliki
  • Λυγούρα, Βασιλική

Subjects

dc:subject × 21

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61519

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Lygoura, Vasiliki; Λυγούρα, Βασιλική. Η μελέτη της φυσικής ιστορίας της πρωτοπαθούς χολικής κίρρωσης. University of Thessaly (UTH), 2025. http://hdl.handle.net/10442/hedi/61519